Merck
MRK
#62
Rank
S$323.53 B
Marketcap
S$129.53
Share price
1.30%
Change (1 day)
-3.27%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): S$9.97

According to Merck's latest financial reports the company's current EPS (TTM) is S$9.81. In 2024 the company made an earnings per share (EPS) of S$8.73 an increase over its 2023 EPS that were of S$0.20.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$9.9714.25%
2024S$8.734308.46%
2023S$0.20-97.32%
2022S$7.4010.92%
2021S$6.6784.68%
2020S$3.61-27.2%
2019S$4.9663.44%
2018S$3.04151.11%
2017S$1.21-54.58%
2016S$2.6630.21%
2015S$2.04-61.99%
2014S$5.38180.51%
2013S$1.92-31.82%
2012S$2.816.62%
2011S$2.64

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$2.22-77.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$13.48 37.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$26.50 170.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$3.84-60.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$4.79-51.20%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
S$4.64-52.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
S$0.81-91.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
S$9.50-3.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Abbott Laboratories
ABT
S$10.40 6.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$16.83 71.59%๐Ÿ‡บ๐Ÿ‡ธ USA